EUVIMEDEUVIMED entdecken
Crossref

Role of METTL14 in cardiomyocyte pyroptosis in mice with heart failure by regulating miR-221-3p RNA methylation

Yingxue Cao, Wei Guo

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yingxue Cao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Shenyang Fourth People's Hospital, Shenyang 110000, China. Electronic address: yingxue_cao@163.com. Hauptthemen laut MEDLINE: Pyroptosis, MicroRNAs, Myocytes, Cardiac, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a serious and chronic condition. Methyltransferase like 14 (METTL14) is an important component of the m6A methyltransferase complex. This study seeks to explore the mechanism by which METTL14 regulates cardiomyocyte pyroptosis in mice with HF, providing a novel target for HF treatment. Both mouse and cell models were treated with doxorubicin (DOX) to induce HF, followed by measurement of heart function parameters and myocardial damage marker. Next, in cell models, the expression of METTL14, miR-221-3p, pri-miR-221, LncRNA FTX, SESN2, and pyroptosis-related factors was detected. The m6A levels of pri-miR-221, the bindings of miR-221-3p to LncRNA FTX and FUS to LncRNA FTX or SESN2, and the interaction between miR-221-3p and LncRNA FTX were detected. We found that METTL14 was overexpressed in mouse and cell models. METTL14-mediated m6A modification upregulated miR-221-3p expression and inhibited LncRNA FTX expression, reducing the binding of LncRNA FTX to FUS, ultimately inhibiting SESN2 expression. Knockout of METTL14 improved heart function, as evidenced by increased EF and FS, decreased LVIDd and LVIDs, and reduced CK, CK-MB, and LDH, and reduced cardiomyocyte pyroptosis (the levels of cleaved Caspase-1, GSDMD-N, NLRP3, IL-18, and IL-1β were decreased). miR-221-3p overexpression or SESN2 downregulation partially reversed the protective effects of METTL14 downregulation on cardiomyocyte pyroptosis and HF. In conclusion, METTL14-mediated m6A modification exacerbates cardiomyocyte pyroptosis and HF through the miR-221-3p/LncRNA FTX/SESN2 axis, highlighting a potential therapeutic target for HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisMicroRNAsMyocytes, CardiacMethyltransferasesHeart FailureAnimalsMiceMaleMice, Inbred C57BLMethylationRNA, Long NoncodingDoxorubicinHumansMice, KnockoutDisease Models, AnimalRNA Methylation

Stichwörter der Autor:innen

Heart failureMETTL14Pyroptosism6AmiR-221-3p

Substanzen

MicroRNAsMethyltransferasesMIRN221 microRNA, mouseRNA, Long NoncodingDoxorubicin

Autor:innen und Institutionen

  • Division of Nephrology, Shenyang Fourth People's Hospital, Shenyang 110000, China. Electronic address: yingxue_cao@163.com.
  • Division of Nephrology, Shenyang Fourth People's Hospital, Shenyang 110000, China.

Zitieren

APA

Cao, Y., & Guo, W. (2025). Role of METTL14 in cardiomyocyte pyroptosis in mice with heart failure by regulating miR-221-3p RNA methylation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114172

Vancouver

Cao Y, Guo W. Role of METTL14 in cardiomyocyte pyroptosis in mice with heart failure by regulating miR-221-3p RNA methylation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114172

BibTeX
@article{Cao2025,
  author = {Cao, Yingxue and Guo, Wei},
  title = {Role of METTL14 in cardiomyocyte pyroptosis in mice with heart failure by regulating miR-221-3p RNA methylation},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114172}
}
Kostenlos starten →